News
As regulations tighten and public spaces become increasingly smoke-free, the tobacco industry is pivoting its strategy, ...
14h
Interesting Engineering on MSNEurope’s supercomputer trial hits 1.2 Tbit/s speeds in 2,175 miles AI data sprintBreaking barriers in speed and distance, Europe just witnessed a record-smashing 1.2 terabit-per-second quantum-safe ...
Vietnamese PM Pham Minh Chinh held talks with his Estonian counterpart Kristen Michal in the capital of Tallinn on June 6 ...
Vietnamese Prime Minister Pham Minh Chinh on June 6 visited the E-Estonia Briefing Centre – a symbol of world-leading digital ...
The largest data center in the world isn't just one site. This guide ranks the top 10 global markets by installed capacity ...
STOCKHOLM, Sweden I June 6, 2025 I Sobi® (STO: SOBI) and Apellis Pharmaceuticals, Inc. today presented new data from the open-label period of the Phase 3 ...
Sobi® (STO: SOBI) and Apellis Pharmaceuticals, Inc. today presented new data from the open-label period of the Phase 3 VALIANT study, investigating Aspaveli® ...
In the VALIANT study, EMPAVELI demonstrated a statistically significant 68% proteinuria reduction versus placebo at Week 26, which was sustained at one year. Additionally, patients treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results